儿童急性髓系白血病9P21区基因甲基化的研究

张丽; 阮敏; 刘晓明; 张家源; 郭晔; 杨文钰; 刘芳; 刘天峰; 王书春; 陈晓娟; 邹尧; 陈玉梅; 竺晓凡

doi:10.7499/j.issn.1008-8830.2015.01.002

PDF(1165 KB)

HTML

中国当代儿科杂志 ›› 2015, Vol. 17 ›› Issue (1) : 6-10. DOI: 10.7499/j.issn.1008-8830.2015.01.002

论著·临床研究

儿童急性髓系白血病9P21区基因甲基化的研究

张丽, 阮敏, 刘晓明, 张家源, 郭晔, 杨文钰, 刘芳, 刘天峰, 王书春, 陈晓娟, 邹尧, 陈玉梅, 竺晓凡

作者信息 +

Methylation of the genes in the 9P21 region in children with acute myeloid leukemia

ZHANG Li, RUAN Min, LIU Xiao-Ming, ZHANG Jia-Yuan, GUO Ye, YANG Wen-Yu, LIU Fang, LIU Tian-Feng, WANG Shu-Chun, CHEN Xiao-Juan, ZOU Yao, CHEN Yu-Mei, ZHU Xiao-Fan

Author information +

文章历史 +

摘要

目的研究9P21 区的CDKN2A 和CDKN2B 基因甲基化在儿童急性髓系白血病(AML)中的发生率及其与临床特征及预后的相关性.方法回顾性分析2010 年4 月至2012 年12 月被诊断为AML 的58 例患儿的临床资料.选取38 例健康志愿儿童为对照组,采集两组儿童的骨髓或外周血,常规提取基因组DNA;应用甲基化特异性- 多重连接酶依赖性探针扩增法(MS-MLPA)检测CDKN2A 和CDKN2B 基因甲基化情况.结果进行检测的健康儿童未发现基因甲基化.58 例患儿中,44 例检测到甲基化探针.CDKN2A 基因甲基化涉及136 bp 和237 bp 探针;CDKN2B 基因甲基化涉及130 bp、210 bp、220 bp 和417 bp 探针.CDKN2A 基因甲基化率仅为5%,而CDKN2B 基因甲基化率为76%.部分探针甲基化与初诊时的性别、血红蛋白和血小板水平有关.结论儿童AML 患者CDKN2B 基因甲基化率较高,而CDKN2A 基因甲基化率较低.

Abstract

Objective To investigate the methylation rate of cyclin-dependent kinase inhibitor 2A (CDKN2A) and cyclin-dependent kinase inhibitor 2B (CDKN2B) in the 9P21 region in children with acute myeloid leukemia (AML) and the association of gene methylation with clinical features and outcomes. Methods The clinical data of 58 children who were newly diagnosed with AML between January 2010 and December 2012 were retrospectively analyzed. Thirtyeight healthy children were recruited as the control group. Genomic DNA was extracted from bone marrow or peripheral blood of the 58 patients and 38 healthy children. The methylation status of CDKN2A and CDKN2B was analyzed by methylation-specific multiplex ligation-dependent probe amplification. Results Gene methylation was not found in healthy children. Methylation probes of 44 patients were detected in 58 patients. The methylation of CDKN2A was detected with 136 bp and 237 bp methylation probes. The methylation of CDKN2B was detected with 130 bp, 210 bp, 220 bp, and 417 bp methylation probes. The methylation rate of CDKN2A was 5%, while the methylation rate of CDKN2B was 76%. The methylation detected by some probes was associated with sex, hemoglobin, and platelet count at the first visit. Conclusions The methylation of CDKN2B is a common event in children with AML, while the methylation of CDKN2A is relatively rare.

导出引用

张丽, 阮敏, 刘晓明, 张家源, 郭晔, 杨文钰, 刘芳, 刘天峰, 王书春, 陈晓娟, 邹尧, 陈玉梅, 竺晓凡. 儿童急性髓系白血病9P21区基因甲基化的研究[J]. 中国当代儿科杂志. 2015, 17(1): 6-10 https://doi.org/10.7499/j.issn.1008-8830.2015.01.002

ZHANG Li, RUAN Min, LIU Xiao-Ming, ZHANG Jia-Yuan, GUO Ye, YANG Wen-Yu, LIU Fang, LIU Tian-Feng, WANG Shu-Chun, CHEN Xiao-Juan, ZOU Yao, CHEN Yu-Mei, ZHU Xiao-Fan. Methylation of the genes in the 9P21 region in children with acute myeloid leukemia[J]. Chinese Journal of Contemporary Pediatrics. 2015, 17(1): 6-10 https://doi.org/10.7499/j.issn.1008-8830.2015.01.002

参考文献

[1] Caligiuri MA, Strout MP, Gilliland DG. Molecular biology of acute myeloid leukemia[J]. Semin Oncol, 1997, 24(1): 32-44.
[2] Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties[J]. Blood, 1998, 92(7): 2322-2333.
[3] 李玉华, 文飞球. DNA 甲基化与儿童白血病的临床研究进展[J]. 中国当代儿科杂志, 2011, 13(2): 174-177.
[4] Schoofs T, Berdel WE, Müller-Tidow C. Origins of aberrant DNA methylation in acute myeloid leukemia[J]. Leukemia, 2014, 28(1): 1-14.
[5] Jasielec J, Saloura V, Godley LA. The mechanistic role of DNA methylation in myeloid leukemogenesis[J]. Leukemia, 2014, 28(9): 1765-1773.
[6] Das PM, Singal R. DNA methylation and cancer[J]. J Clin Oncol, 2004, 22(22): 4632-4642.
[7] Galm O, Wilop S, Lüders C, et al. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia[J]. Ann Hematol, 2005, 84 Suppl 1: 39-46.
[8] Agrawal S, Unterberg M, Koschmieder S, et al. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia[J]. Cancer Res, 2007, 67(3): 1370-1377.
[9] Recio JA, Noonan FP, Takayama H, et al. Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis[J]. Cancer Res, 2002, 62(22): 6724-6730.
[10] Bazan V, Zanna I, Migliavacca M, et al. Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma[J]. J Cell Physiol, 2002, 192(3): 286-293.
[11] 范丽萍, 沈建箴, 叶宝国, 等. 巢式MSP 法检测急性白血病患者p16 基因甲基化状态[J]. 中国实验血液学杂志, 2007, 15(2): 258-261.
[12] Cechova H, Lassuthova P, Novakova L, et al. Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia[J]. Neoplasma, 2012, 59(2): 168-174.
[13] Tsukimoto I, Tawa A, Horibe K, et al. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group[J]. J Clin Oncol, 2009, 27(24): 4007-4013.
[14] Mrózek K, Marcucci G, Paschka P, et al. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?[J]. Blood, 2007, 109(2): 431-448.
[15] Caiafa P, Zampieri M. DNA methylation and chromatin structure: the puzzling CpG islands[J]. J Cell Biochem, 2005, 94(2): 257-265.
[16] Herman JG, Graff JR, Myöhänen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands[J]. Proc Natl Acad Sci U S A, 1996, 93(18): 9821-9826.
[17] Tien HF, Tang JH, Tsay W, et al. Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation[J]. Br J Haematol, 2001, 112(1): 148-154.
[18] Chim CS, Kwong YL. Adverse prognostic impact of CDKN2B hyper-methylation in acute promyelocytic leukemia[J]. Leuk Lymphoma, 2006, 47(5): 815-825.
[19] Au WY, Fung AT, Ma ES, et al. Serial studies of methylation of CDKN2B and CDKN2A in relapsed acute promyelocytic leukaemia treated with arsenic trioxide[J]. Br J Haematol, 2005, 131(5): 632-635.
[20] Markus J, Garin MT, Bies J, et al. Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16)[J]. Cancer Res, 2007, 67(3): 992-1000.
[21] 周剑锋, 张丽, 曾慧敏, 等. 儿童急性髓系白血病DNMT3a 基因突变的分析[J]. 中国实验血液学杂志, 2012, 20(6): 1297-1301.
[22] 张丽, 曾慧敏, 艾晓非, 等. 儿童急性髓系白血病NPMl 和 IDH 基因突变的研究[J]. 中华血液学杂志, 2013, 34(5): 449-452.
[23] 任媛媛, 竺晓凡. 儿童骨髓增生异常综合征分子生物学研究进展[J]. 中国当代儿科杂志, 2014, 16(9): 957-961.
[24] Pleyer L, Burgstaller S, Girschikofsky M, et al. Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group[J]. Ann Hematol, 2014, 93(11): 1825-1838.